Singapore, April 15, 2008: US-based Amarillo Biosciences has appointed Dr Peter Mueller as Chief Operating Officer and Director of Research. Dr. Mueller will be responsible for R&D, business development, licensing, global commercial development, production and administration at the company

 

Dr Mueller has more than 20 years of global experience in the pharmaceutical industry. Most recently, he has headed Epicenter Consulting, a New Jersey-based health care consulting firm that he founded in 2001. Previously, Dr Mueller was Vice President, Global Marketing & Medical Information and Technology for Aventis Pharmaceuticals. Before that, he served as Vice President, Global Marketing Business & Marketing Services for Hoechst Marion Roussel. He was also Director, Global Commercial Development, Cardiovascular and Metabolism for Marion Merrell Dow.

 

Dr Joseph Cummins, President and CEO of Amarillo Biosciences said, Peter is a dynamic and results-driven executive with extensive global experience in the pharmaceutical industry. His organizational skills will greatly aid Amarillo's efforts to achieve FDA approval for the utilization of low-dose interferon in the treatment of multiple medical conditions.